November 3, 2008

Urodynamix Appoints Chief Financial Officer

VANCOUVER, British Columbia, November 3, 2008 - Urodynamix Technologies Ltd., (“Urodynamix”) (TSX-V:URO) today announced the appointment of Jonathan Jackson, CA as Chief Financial Officer. 

Mr. Jackson has held CFO and VP Finance roles in high-tech and manufacturing companies for the past 12 years and was most recently the Chief Financial Officer at Extreme CCTV Inc., where he successfully completed the sale of that company to Robert Bosch GmbH of Germany. Mr. Jackson has a Bachelor of Commerce degree from the University of Saskatchewan and is a member of the Institute of Chartered Accountants of British Columbia.

“We are very pleased to have Jonathan join the management team of Urodynamix,” said Barry Allen, President and CEO. “Jonathan will play a critical part in our strategy of partnering with healthcare and medical device companies to bring innovative new products to market. We are confident that Jonathan’s experience will be instrumental in commercializing our technologies and contribute importantly to our business strategy and growth.”

As part of his compensation, the Company has granted 200,000 incentive stock options to Mr. Jackson. The stock options are being offered in conformance with TSX Venture Exchange regulations as incentive compensation and have a term of five years and an exercise price of $0.10 per share.

About Urodynamix Technologies Ltd.

Urodynamix is a Canadian medical device company developing and commercializing non-invasive medical technology based on proprietary applications of near-infrared spectroscopy (NIRS). The Company is currently focused on products that aid in the diagnosis and treatment of urinary incontinence, lower urinary tract symptoms, erectile dysfunction, prostate cancer, benign prostatic hyperplasia, and traumatic increases in intra-abdominal pressure that cause abdominal compartment syndrome. Urodynamix’s breakthrough medical technology has the potential to beneficially affect more than 200 million people worldwide.

Certain information contained in this press release may be forward-looking and is subject to unknown risks, which could cause actual results to differ materially from those set forth or implied herein. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

For more information, please contact:

Kuljeet Manj

Manager, Corporate Communications

Urodynamix Technologies Ltd.

Tel: (604) 638-0117

Email: kmanj@urodynamix.com